BVMF/PGMN3 (BVMF/PGMN3)

Brazil Stock Exchange: BVMF/PGMN3 · BRL

R$2.57

-0.12 (-4.5%)· Recorded snapshot

Market cap	1.9B
Revenue (ttm)	15.6B
Net income (ttm)	328.4M
EPS (ttm)	R$0.49
Shares out	720.1M
P/E (trailing)	5.2x
P/E (forward)	4.5x
Dividend	R$0.26 (10.03%)
Volume	17,703,200
Beta	0.05

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 15.6B
Net income (ttm): 328.4M
EPS (ttm): R$0.49
P/E (trailing): 5.2x
P/E (forward): 4.5x
Market cap: 1.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E4.5

P25 n/aP50 n/aP75 n/a

Trailing P/E5.2

P25 n/aP50 n/aP75 n/a

ROE10.6

P25 n/aP50 n/aP75 n/a

ROIC14.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/PGMN3 indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

BRL

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Brazil
Country code	BR
Earnings date	2026-11-04
Employees	28,534
Employees change	1,292
Employees growth	4.74%
Enterprise value	BRL 5.2B
Exchange	Brazil Stock Exchange
Financial currency	BRL
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1981
Industry	Pharmaceutical Retailers
Is primary listing	Yes
ISIN number	BRPGMNACNOR8
Last earnings date	2026-08-03
Last refreshed	2026-10-29
Market cap	BRL 1.9B
Next earnings date	2026-11-04
Price	BRL 2.57
Price currency	BRL
Sector	Healthcare
SIC code	5912
Stock price date	2026-10-29
Symbol	bvmf/PGMN3
Website	https://www.paguemenos.com.br

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	85.99x
Average P/E ratio (5Y)	65.05x
Earnings yield	19.08%
EV/Earnings	16.2x
EV/EBIT	5.59x
EV/EBITDA	4.16x
EV/FCF	60.15x
EV/Sales	0.34x
FCF / EV yield	1.66%
FCF yield	4.57%
Forward P/E	4.51x
Graham number	7.23624
Graham upside	176.19%
Lynch fair value	BRL 5.60
Lynch upside	113.82%
P/B ratio	0.57x
P/E ratio	5.24x
P/FCF ratio	21.9x
P/OCF ratio	5.66x
P/S ratio	0.12x
PEG ratio	0.16x
Price / tangible book value	0.6x
Price/EBITDA ratio	2.06x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	6.06%
EBITDA margin	6.01%
FCF margin	0.57%
Gross margin	32.3%
Operating margin	6.06%
Pretax margin	1.71%
Profit margin	2.1%
Profit per employee	BRL 11,509
Profitable quarters	9
Profitable years	6
Revenue per employee	BRL 548,030
ROA	6.26%
ROA (5Y)	3.87%
ROCE	14.26%
ROE	10.59%
ROE (5Y)	6.59%
ROIC	14.06%
ROIC (5Y)	9.13%
Tax / revenue	-0.39%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	90.05%
EPS growth (Q)	11.11%
EPS growth (QoQ)	29.72%
EPS growth 3Y	10.35%
EPS growth 5Y	1.8%
EPS growth quarters	6
EPS growth years	2
FCF growth	-61.73%
FCF growth 3Y	18.15%
Gross profit growth	15.83%
Gross profit growth (Q)	8.86%
Gross profit growth 3Y	14.35%
Gross profit growth 5Y	16.86%
Net income growth	102.02%
Net income growth (Q)	41.56%
Net income growth (QoQ)	36.19%
Net income growth 3Y	26.12%
Net income growth 5Y	11.42%
Net income growth quarters	6
Net income growth years	2
OCF growth	1.25%
OCF growth (QoQ)	-17.02%
OCF growth 10Y	4.42%
OCF growth 3Y	8.65%
Operating income growth	38.67%
Operating income growth (Q)	18.64%
Operating income growth 3Y	41.39%
Operating income growth 5Y	18.78%
Revenue growth	14.27%
Revenue growth (Q)	7.96%
Revenue growth (QoQ)	4.71%
Revenue growth 10Y	12.07%
Revenue growth 3Y	13.83%
Revenue growth 5Y	16.51%
Revenue growth quarters	24
Revenue growth years	16

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -253.7M
Depreciation and amortization	BRL -8.8M
EBIT	BRL 948.4M
EBITDA	BRL 939.6M
EPS	BRL 0.49
FCF per share	BRL 0.12
Financing cash flow	BRL -160.2M
Free cash flow	BRL 88.5M
Gross profit	BRL 5.1B
Income taxes	BRL -61.4M
Investing cash flow	BRL -315.3M
Net borrowing	BRL -421.9M
Net cash flow	BRL -133.3M
Net income	BRL 328.4M
Operating income	BRL 948.4M
Revenue	BRL 15.6B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.62
Book value per share	BRL 4.75
Debt / EBITDA	2.74
Debt / equity	1.02
Debt / FCF	39.42
Interest coverage	1.86
Long-term assets	BRL 4.2B
Long-term liabilities	BRL 3.2B
Net cash (debt)	BRL -3.4B
Net cash / market cap	-174.27%
Net debt / EBITDA	3.59
Net debt / equity	0.99
Net debt / FCF	38.16
Piotroski F-Score	7
Property, plant and equipment	BRL 2.5B
Shareholders' equity	BRL 3.4B
Tangible book value	BRL 3.2B
Tangible book value per share	BRL 4.47
Total assets	BRL 9.8B
Total cash	BRL 111.2M
Total debt	BRL 3.5B
Total liabilities	BRL 6.4B
WACC	9.05%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.65
Current assets	BRL 5.7B
Current liabilities	BRL 3.2B
Current ratio	1.78
Inventory turnover	3.11
Net working capital	BRL 2.7B
Quick ratio	0.57
Working capital	BRL 2.5B
Working capital turnover	7.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-9.12%
Dividend growth	1.88%
Dividend growth years	2
Dividend payment date	2026-02-02
Dividend payment years	3
Dividend payout frequency	Annual
Dividend per share	BRL 0.26
Dividend yield	10.03%
Ex-dividend date	2025-12-26
FCF payout ratio	178.3%
Last dividend	BRL 0.22
Payout ratio	31.39%
Shareholder yield	0.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 4.24
1D price change	-4.46%
1M price change	-22.32%
1M total return	-22.32%
1W price change	-53.39%
1W total return	-53.39%
1Y price change	-30.77%
1Y return CAGR	-27.94%
1Y total return	-27.92%
20-day SMA	BRL 4.56
200-day SMA	BRL 4.83
3M price change	-18.18%
3M total return	-18.18%
3Y price change	-15.26%
3Y return CAGR	1.18%
3Y total return	3.58%
50-day SMA	BRL 3.99
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 7.62
52-week high date	2026-02-20
52-week low	BRL 2.55
52-week low date	2026-10-29
5Y price change	-72.61%
5Y return CAGR	-18.65%
5Y total return	-64.37%
6M price change	-52.8%
6M total return	-52.8%
All-time high	BRL 13.75
All-time high date	2021-09-14
All-time low	BRL 2.16
All-time low date	2024-06-18
Average true range (ATR)	BRL 0.43
Average volume	16.9M
Beta (1Y)	0.23
Beta (2Y)	-0.02
Beta (5Y)	0.05
Change from 52-week high	-66.27%
Change from 52-week low	0.78%
Change from all-time high	-81.02%
Change from all-time low	20.83%
Change from open	-4.1%
Day's gap	-0.37%
Dollar volume	BRL 45.5M
High price	BRL 2.70
Low price	BRL 2.55
Monthly RSI	38.46
Open price	BRL 2.68
Position in 52-week range	13.33%
Previous close	BRL 2.69
Price vs 150-day SMA	-38.43%
Price vs 20-day SMA	-42.73%
Price vs 200-day SMA	-45.93%
Price vs 50-day SMA	-34.6%
Relative volume	1.05
RSI	31.2
Sharpe ratio	-0.1
Sharpe ratio (3Y)	0.26
Sharpe ratio (5Y)	-0.26
Sortino ratio	-0.05
Sortino ratio (3Y)	0.45
Sortino ratio (5Y)	-0.25
Volume	17.7M
Weekly RSI	37.92
YTD price change	-57.14%
YTD total return	-57.14%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	168.7M
Shares change (QoQ)	3.24%
Shares change (YoY)	9.12%
Shares held by insiders	58.63%
Shares held by institutions	11.02%
Shares outstanding	720.1M

Deeper analysis on BVMF/PGMN3

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/PGMN3 report

Is a complete BVMF/PGMN3 research report available?

No complete published report is available for bvmf/PGMN3 (BVMF/PGMN3) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/PGMN3 (BVMF/PGMN3)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/PGMN3

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/PGMN3 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/PGMN3

Frequently asked questions